deltatrials
Completed PHASE4 NCT00535925

Nephropathy In Type 2 Diabetes and Cardio-renal Events

Nephropathy in Type 2 Diabetes: Effects of an Intensive Multifactorial Intervention Trial on Cardio-renal Events.

Sponsor: University of Campania Luigi Vanvitelli

Updated 11 times since 2017 Last updated: Jul 31, 2020 Started: Oct 31, 2005 Primary completion: Dec 31, 2011 Completion: May 31, 2019

Listed as NCT00535925, this PHASE4 trial focuses on Diabetic Nephropathy and remains completed. Sponsored by University of Campania Luigi Vanvitelli, it has been updated 11 times since 2005, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

11 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

Show 6 earlier versions
  1. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jul 2020 — Sep 2020 [monthly]

    Completed PHASE4

  3. Jun 2020 — Jul 2020 [monthly]

    Completed PHASE4

    Status: Unknown StatusCompleted

  4. Jun 2018 — Jun 2020 [monthly]

    Unknown Status PHASE4

  5. Sep 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

  6. Jan 2017 — Sep 2017 [monthly]

    Unknown Status PHASE4

    First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Campania Luigi Vanvitelli
Data source: University of Campania Luigi Vanvitelli

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Naples, Italy